John Barnes

Best Publications

• Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans

  Rebecca J. Garten;C. Todd Davis;Colin A. Russell;Colin A. Russell;Bo Shu

  3408
  Citations

• Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021.

  Sonja J Olsen;Amber K Winn;Alicia P Budd;Mila M Prill

  678
  Citations

• Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021.

  Sonja J Olsen;Amber K Winn;Alicia P Budd;Mila M Prill

  584
  Citations

• Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.

  Mark G Thompson;Jefferey L Burgess;Allison L Naleway;Harmony Tyner

  515
  Citations

• SARS-CoV-2 spike D614G change enhances replication and transmission.

  Bin Zhou;Tran Thi Nhu Thao;Donata Hoffmann;Adriano Taddeo

  487
  Citations

• Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants

  Unknown

  391
  Citations

• Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022

  Unknown

  339
  Citations

• Influenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine

  Stacy L Davlin;Lenee Blanton;Krista Kniss;Desiree Mustaquim

  290
  Citations

• Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker

  Unknown

  283
  Citations

• Viral deep sequencing needs an adaptive approach: IRMA, the iterative refinement meta-assembler

  Samuel S. Shepard;Sarah Meno;Justin Bahl;Malania M. Wilson;Malania M. Wilson

  261
  Citations

• Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine

  Rebecca Garten

  257
  Citations

• Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

  Brendan Flannery;Jessie R. Chung;Edward A. Belongia;Huong Q. McLean

  222
  Citations

• Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.

  Brendan Flannery;Rebecca J Garten Kondor;Jessie R Chung;Manjusha Gaglani

  219
  Citations

• Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.

  Fatimah S. Dawood;Jessie R. Chung;Sara S. Kim;Richard K. Zimmerman

  160
  Citations

• Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.

  Brendan Flannery;Swathi N. Thaker;Jessie Clippard;Arnold S. Monto

  143
  Citations

• Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans

  Unknown

  143
  Citations

• Direct RNA Sequencing of the Coding Complete Influenza A Virus Genome.

  Matthew W. Keller;Benjamin L. Rambo-Martin;Malania M. Wilson;Callie A. Ridenour

  142
  Citations

• Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines

  Mark G Thompson;Jefferey L Burgess;Allison Naleway;Harmony Tyner

  135
  Citations

• Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

  Brendan Flannery;Richard K. Zimmerman;Larisa V. Gubareva;Rebecca J. Garten

  130
  Citations

• Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season

  Brendan Flannery;Jessie R Chung;Arnold S Monto;Emily T Martin

  125
  Citations